Antimicrobial Stewardship Series: Antimicrobial Stewardship in Dental Practice: Principles & Practice

Friday, June 27, 2025, 12:00 PM - 1:00 PM, Online

Antibiotic stewardship has taken on new importance with the emergence of superbugs and the decline in effective and available oral antibiotics. Professor Baker will present an update on recent developments in dental antibiotic prescribing and outline strategies for prescribing to ensure therapeutic success with minimum risk. Difficult questions about antibiotic prophylaxis will be examined and all relevant guidelines and decision tools will be included.

---

Pre-registration is not required. Join the Zoom meeting at this link: https://uiowa.zoom.us/j/96567367590?pwd=emmjWi2wBOlXRka1pFf8Vm30i4nvkF.1

Contact Erika Ernst for additional information: [email protected], 319-335-8785

---

AMA PRA Category 1 Credits™ (1.00 hours), ACPE Credit (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Attendance (1.00 hours)

1. Select regimens for odontogenic infections based on allergies, intolerances, effectiveness, Black Box Warnings, and current guidelines.
2. Prescribe antibiotic prophylaxis for selected patients with a variety of implants including cardiac and orthopedic devices
3. Discuss the pros and cons of prophylactic antibiotics for implant placement, tooth extractions, and other surgical procedures in dental practice

In support of improving patient care, this activity has been planned and implemented by the University of Iowa Roy J. and Lucille A. Carver College of Medicine, The University of Iowa College of Pharmacy, and Iowa Department of Health and Human Services. The University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 1.0 ANCC contact hours.

Pharmacist: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 1.0 ACPE contact hour(s). Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. Pharmacist UAN: JA0000310-9999-25-068-L01-P

Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Care Providers:  A certificate of participation will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)

Disclosure Policy: Everyone in a position to control the content of this educational activity will disclose to the accredited provider all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosures:

• Erika Ernst - Merck & Co. - sponsored research

• Other faculty/planners/reviewers disclosed no relevant financial relationships.

Relevant financial relationships were mitigated.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, June 27, 2025